[HTML][HTML] Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal

P Valent, C Akin, K Hartmann, I Alvarez-Twose… - …, 2021 - journals.lww.com
Mastocytosis is a hematologic neoplasm characterized by expansion and focal
accumulation of neoplastic mast cells (MC) in diverse organs, including the skin, bone …

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines

KA Risma, KM Edwards, DS Hummell, FF Little… - Journal of Allergy and …, 2021 - Elsevier
Anaphylaxis to vaccines is historically a rare event. The coronavirus disease 2019 pandemic
drove the need for rapid vaccine production applying a novel antigen delivery system …

New insights into the pathogenesis of mastocytosis: emerging concepts in diagnosis and therapy

P Valent, C Akin, WR Sperr, HP Horny… - Annual Review of …, 2023 - annualreviews.org
Mastocytosis is a heterogeneous group of neoplasms defined by a numerical increase and
accumulation of clonal mast cells (MCs) in various organ systems. The disease may present …

Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives

V Sampath, G Rabinowitz, M Shah, S Jain, Z Diamant… - Allergy, 2021 - Wiley Online Library
Vaccines are essential public health tools with a favorable safety profile and prophylactic
effectiveness that have historically played significant roles in reducing infectious disease …

The ingenious mast cell: Contemporary insights into mast cell behavior and function

JS Dahlin, M Maurer, DD Metcalfe, G Pejler… - Allergy, 2022 - Wiley Online Library
Mast cells are (in) famous for their role in allergic diseases, but the physiological and
pathophysiological roles of this ingenious cell are still not fully understood. Mast cells are …

Mast cell activation syndromes: collegium internationale allergologicum update 2022

P Valent, K Hartmann, P Bonadonna… - International archives of …, 2022 - karger.com
Mast cell activation syndromes (MCASs) are defined by systemic severe and recurrent mast
cell activation, usually in form of anaphylaxis, a substantial, event-related increase of the …

[HTML][HTML] Personalized management strategies in mast cell disorders: ECNM-AIM user's guide for daily clinical practice

P Valent, K Hartmann, J Schwaab… - The Journal of Allergy …, 2022 - Elsevier
Mastocytosis is a myeloid neoplasm defined by expansion and focal accumulation of clonal
mast cells (MCs) in one or more organs. The disease exhibits a complex pathology and may …

Hereditary alpha tryptasemia is not associated with specific clinical phenotypes

MB Chollet, C Akin - Journal of Allergy and Clinical Immunology, 2022 - Elsevier
Background Hereditary alpha tryptasemia (HαT) is found in approximately 7% of the
population. Associations with a variety of clinical symptoms including gastric reflux, joint …

Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals

D González‐de‐Olano, P Navarro‐Navarro… - Allergy, 2024 - Wiley Online Library
Background A close association between hereditary alpha‐tryptasemia (HAT) and mast cell
(MC) disorders has been previously reported. However, the relationship between HAT and …

The international consensus classification of mastocytosis and related entities

RJ Leguit, SA Wang, TI George, A Tzankov, A Orazi - Virchows Archiv, 2023 - Springer
Mastocytosis is a neoplasm characterized by a clonal proliferation of mast cells, which
accumulate in one or multiple organs, associated with an extremely heterogeneous clinical …